DEF: Taylor Devices Schedules 2025 Annual Meeting, Proposes New Stock Option Plan

Taylor Devices, Inc. announced its 2025 Annual Meeting of Shareholders to be held on October 17, 2025, where shareholders will vote on director election, auditor ratification, and a new stock option plan.

Summary

• The 2025 Annual Meeting of Shareholders will be held on October 17, 2025, in Amherst, New York, with a record date of August 18, 2025.
• Shareholders will vote on the re-election of Robert Carey as a Class 3 director, the ratification of Lumsden & McCormick, LLP as the independent auditor for fiscal year 2026, and the approval of the 2025 Taylor Devices, Inc. Stock Option Plan.
• The proposed 2025 Stock Option Plan reserves a maximum of 316,200 shares for grants to employees and directors, aiming to incentivize and align interests with shareholders.
• The plan would increase the fully diluted overhang from approximately 11.9% to 18.5% if approved.
• Alan R. Klembczyk retired as President on June 1, 2025, and will retire from the Board at the upcoming Annual Meeting, reducing the Board size from five to four directors.
• Net income for fiscal year 2025 was $9,413,136, an increase from $8,998,762 in fiscal year 2024 and $6,287,358 in fiscal year 2023.
• Total Shareholder Return (TSR) for a $100 investment was $393 in 2025, down from $526 in 2024, but up from $198 in 2023.
• Executive compensation for the CEO, President, and CFO included base salaries, bonuses, and option awards, with total compensation for the CEO being $631,696 in FY2025, down from $755,904 in FY2024.

Sentiment

Score: 7

Explanation: The filing outlines standard corporate governance matters, including director elections and auditor ratification. The proposed 2025 Stock Option Plan is a positive for incentivizing management and directors, though it introduces a higher potential for shareholder dilution. The reported increase in net income for FY2025 is a positive financial indicator, despite a decrease in Total Shareholder Return for the same period.

Positives

• Net income increased to $9,413,136 in fiscal year 2025 from $8,998,762 in fiscal year 2024, demonstrating continued financial growth.
• The company maintains a strong corporate governance structure with independent directors comprising key committees (Audit, Compensation, Nominating).
• The proposed 2025 Stock Option Plan aims to align employee and director incentives with shareholder interests through equity ownership.
• All Section 16(a) reports for executive officers, directors, and 10% beneficial owners were filed timely during the fiscal year ended May 31, 2025.

Negatives

• The fully diluted overhang would increase from approximately 11.9% to 18.5% if the 2025 Stock Option Plan is approved, indicating potential dilution for existing shareholders.
• Total Shareholder Return (TSR) for a $100 investment decreased from $526 in fiscal year 2024 to $393 in fiscal year 2025, suggesting a decline in shareholder value during the most recent fiscal year.
• Total compensation for the CEO decreased from $755,904 in FY2024 to $631,696 in FY2025, primarily due to a reduction in bonus amount.

Risks

• Potential shareholder dilution from the proposed 2025 Stock Option Plan, which would increase the fully diluted overhang to approximately 18.5%.
• The company's ability to attract and retain key talent may be impacted by the effectiveness of its compensation plans, including the proposed stock option plan.
• Changes in capital structure or control events could affect outstanding options, as outlined in the 'Change in Control' provisions of the 2025 Stock Option Plan.
• Adverse tax consequences for optionees or the company under Section 409A or other Code provisions, though the plan is intended to be exempt from Section 409A.

Future Outlook

The company intends to continue its strategy of incentivizing employees and directors through equity compensation, as evidenced by the proposed 2025 Stock Option Plan. The Board believes its current leadership structure and composition are effective for identifying strategic priorities and opportunities, and for executing the company's strategy to achieve long-term success.

Management Comments

• The nominee [Robert Carey] has professional experience in areas relevant to our strategy and operations.
• Messrs. Burgess and Sopko are best suited to serve in their respective roles because their collective knowledge and experience within the industry will allow them to identify strategic priorities and opportunities, and thus more effectively execute the Company's strategy and achieve long-term success.
• The Board is committed to seeking to limit shareholder dilution from our equity compensation program.
• The present size of the Board, and the size of the Board following the Annual Meeting, is appropriate given the size and operations of the Company.

Industry Context

The filing primarily focuses on internal corporate governance, executive compensation, and a new stock option plan, which are standard practices for publicly traded companies. The company operates in specialized manufacturing sectors (e.g., aerospace, defense, industrial, structural applications, medical, food processing, biotechnology research, high-energy batteries for rugged environments), and the proposed stock option plan is a common tool used across industries to attract and retain talent and align management incentives with shareholder interests. The mention of ISO 9001, ISO 14000, and AS9100 certifications for quality systems indicates adherence to high industry standards, particularly relevant for its military and aerospace involvement.

Comparison to Industry Standards

• The company's use of a classified board structure with staggered terms for directors is a common, though sometimes debated, corporate governance practice.
• The proposed 2025 Stock Option Plan, with its share reserve and annual grants, is a standard equity compensation mechanism, comparable to those used by other public companies to incentivize employees and directors. The increase in fully diluted overhang to 18.5% should be evaluated against peer companies' average dilution levels.
• The auditor fees for Lumsden & McCormick, LLP ($138,000 in FY2025) are within typical ranges for a company of Taylor Devices' size and complexity, though specific comparisons would require detailed peer data.
• The company's adherence to ISO 9001, ISO 14000, and AS9100 standards for its quality system is a strong indicator of commitment to quality and operational excellence, particularly important in the aerospace and defense sectors where competitors like Moog, Inc. (mentioned in John Burgess's bio) also operate.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Potential dilution from the new stock option plan (overhang increasing to 18.5%); opportunity to vote on key governance matters and director election; potential for long-term value creation through incentivized management.
• Employees: Opportunity to receive stock options under the new 2025 Plan, providing an incentive for performance and retention; continued employment agreements for key executives with severance benefits.
• Directors: Continued compensation through retainer fees and stock options; re-election of Robert Carey; enhanced protection through indemnification insurance.
• Management: Incentivized through stock options and performance-based bonuses; clear employment agreements for CEO and CFO.
• Auditors: Lumsden & McCormick, LLP proposed for re-ratification for fiscal year 2026.

Next Steps

• Shareholders to vote on director election, auditor ratification, and the 2025 Stock Option Plan at the Annual Meeting on October 17, 2025.
• If approved, the 2025 Stock Option Plan will become effective on October 17, 2025, and the company will file a Form S-8 registration statement.
• Annual stock option grants to directors under the 2025 Plan will commence on April 18, 2026.
• Shareholders wishing to submit proposals for the 2026 Annual Meeting must do so by May 8, 2026 (Rule 14a-8) or follow advance notice procedures for other matters.

Key Dates

Recommendation

This filing is a routine proxy statement primarily focused on corporate governance, director elections, and a new stock option plan. While the increase in net income is positive, the decrease in TSR for the most recent fiscal year and the potential for increased dilution from the new stock option plan present mixed signals. There are no immediate catalysts or red flags that would warrant a strong buy or sell recommendation based solely on this filing. A 'hold' recommendation is appropriate as investors should maintain their current position while monitoring future financial performance and strategic developments.

Keywords

Taylor Devices, SEC Filing, Proxy Statement, Annual Meeting, Corporate Governance, Stock Option Plan, Executive Compensation, Director Election, Auditor Ratification, Shareholder Meeting, DEF 14A, Equity Compensation, Risk Oversight, Financial Performance, Net Income, Total Shareholder Return